Clinical Trial Update: MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for MEDITOXIN treatment in a subject with benign masseteric hypertrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Masseter Muscle Hypertrophy

Drugs mentioned

• Meditoxin (botulinum toxin type A)

Snippet

Sponsor: Medy-Tox | Conditions: Masseter Muscle Hypertrophy | Phase 3 | Status: COMPLETED